These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6659543)

  • 21. Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat.
    Conte A; Palmieri L; Segnini D; Ronca G
    Drugs Exp Clin Res; 1991; 17(1):27-33. PubMed ID: 1914833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of pidotimod in rats and dogs.
    Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic fate of the novel antihypertensive drug naftopidil.
    Peter G; Niebch G; Locher M; Borbe HO
    Arzneimittelforschung; 1991 Sep; 41(9):924-31. PubMed ID: 1796920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative bioavailability of levamisole in non lactating ewes and goats.
    Galtier P; Escoula L; Camguilhem R; Alvinerie M
    Ann Rech Vet; 1981; 12(2):109-15. PubMed ID: 7342829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
    Klecker RW; Jamis-Dow CA; Egorin MJ; Erkmen K; Parker RJ; Stevens R; Collins JM
    Drug Metab Dispos; 1994; 22(2):254-8. PubMed ID: 7912177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic fate of the new anti-ulcer drug enprostil in animals. 3rd communication: tissue accumulation after consecutive oral administration of [3H]-enprostil in rats.
    Kohno M; Naito K; Yamada Y; Nakahara M; Otsuka M; Takaiti O; Parnes H; Chaplin M
    Arzneimittelforschung; 1989 Mar; 39(3):350-6. PubMed ID: 2502988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
    Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of 3H-pipethiaden after single oral and intravenous administration in rats.
    Lapka R; Franc Z; Smolik S
    Arzneimittelforschung; 1985; 35(2):486-8. PubMed ID: 4039570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition of the opioid antagonist, LY255582, in rats and dogs.
    Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T
    Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disposition and metabolism of amosulalol hydrochloride, a new combined alpha- and beta-adrenoceptor blocking agent, in rats, dogs and monkeys.
    Sasaki H; Kamimura H; Kaniwa H; Kawamura S; Takaichi M; Yokoshima T
    Xenobiotica; 1984 Aug; 14(8):621-31. PubMed ID: 6149657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C]nisoldipine to rats and dogs.
    Ahr HJ; Krause HP; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1099-104. PubMed ID: 3196403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.